LIVANOVA PLC (LIVN) Fundamental Analysis & Valuation

NASDAQ:LIVN • GB00BYMT0J19

61.93 USD
-0.13 (-0.21%)
At close: Mar 10, 2026
61.93 USD
0 (0%)
After Hours: 3/10/2026, 4:30:03 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This LIVN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

LIVN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. LIVN has an average financial health and profitability rating. LIVN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. LIVN Profitability Analysis

1.1 Basic Checks

  • LIVN had positive earnings in the past year.
  • In the past year LIVN had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: LIVN reported negative net income in multiple years.
  • In the past 5 years LIVN always reported a positive cash flow from operatings.
LIVN Yearly Net Income VS EBIT VS OCF VS FCFLIVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M

1.2 Ratios

  • With a decent Return On Assets value of -9.30%, LIVN is doing good in the industry, outperforming 61.41% of the companies in the same industry.
  • LIVN has a better Return On Equity (-20.21%) than 60.87% of its industry peers.
  • LIVN has a better Return On Invested Capital (8.12%) than 83.15% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for LIVN is below the industry average of 9.15%.
  • The 3 year average ROIC (5.19%) for LIVN is below the current ROIC(8.12%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -9.3%
ROE -20.21%
ROIC 8.12%
ROA(3y)-2.02%
ROA(5y)-3.2%
ROE(3y)-4.68%
ROE(5y)-6.34%
ROIC(3y)5.19%
ROIC(5y)4.15%
LIVN Yearly ROA, ROE, ROICLIVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20 -30

1.3 Margins

  • Looking at the Operating Margin, with a value of 14.69%, LIVN belongs to the top of the industry, outperforming 82.07% of the companies in the same industry.
  • In the last couple of years the Operating Margin of LIVN has grown nicely.
  • The Gross Margin of LIVN (68.04%) is better than 74.46% of its industry peers.
  • LIVN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.69%
PM (TTM) N/A
GM 68.04%
OM growth 3Y22.55%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.73%
GM growth 5Y1.24%
LIVN Yearly Profit, Operating, Gross MarginsLIVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. LIVN Health Analysis

2.1 Basic Checks

  • LIVN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • LIVN has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for LIVN has been increased compared to 5 years ago.
  • The debt/assets ratio for LIVN has been reduced compared to a year ago.
LIVN Yearly Shares OutstandingLIVN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
LIVN Yearly Total Debt VS Total AssetsLIVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • Based on the Altman-Z score of 1.76, we must say that LIVN is in the distress zone and has some risk of bankruptcy.
  • LIVN has a Altman-Z score (1.76) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of LIVN is 2.17, which is a good value as it means it would take LIVN, 2.17 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 2.17, LIVN belongs to the top of the industry, outperforming 86.41% of the companies in the same industry.
  • LIVN has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of LIVN (0.29) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 2.17
Altman-Z 1.76
ROIC/WACC0.93
WACC8.7%
LIVN Yearly LT Debt VS Equity VS FCFLIVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • LIVN has a Current Ratio of 1.36. This is a normal value and indicates that LIVN is financially healthy and should not expect problems in meeting its short term obligations.
  • LIVN's Current ratio of 1.36 is on the low side compared to the rest of the industry. LIVN is outperformed by 79.35% of its industry peers.
  • LIVN has a Quick Ratio of 1.16. This is a normal value and indicates that LIVN is financially healthy and should not expect problems in meeting its short term obligations.
  • LIVN's Quick ratio of 1.16 is on the low side compared to the rest of the industry. LIVN is outperformed by 70.11% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1.16
LIVN Yearly Current Assets VS Current LiabilitesLIVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. LIVN Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 15.73% over the past year.
  • Measured over the past years, LIVN shows a very strong growth in Earnings Per Share. The EPS has been growing by 25.16% on average per year.
  • LIVN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.74%.
  • Measured over the past years, LIVN shows a quite strong growth in Revenue. The Revenue has been growing by 8.24% on average per year.
EPS 1Y (TTM)15.73%
EPS 3Y17.57%
EPS 5Y25.16%
EPS Q2Q%6.17%
Revenue 1Y (TTM)10.74%
Revenue growth 3Y10.75%
Revenue growth 5Y8.24%
Sales Q2Q%12.15%

3.2 Future

  • LIVN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.89% yearly.
  • The Revenue is expected to grow by 6.16% on average over the next years.
EPS Next Y9.85%
EPS Next 2Y8.87%
EPS Next 3Y9.5%
EPS Next 5Y10.89%
Revenue Next Year7.68%
Revenue Next 2Y7.17%
Revenue Next 3Y7.09%
Revenue Next 5Y6.16%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
LIVN Yearly Revenue VS EstimatesLIVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
LIVN Yearly EPS VS EstimatesLIVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. LIVN Valuation Analysis

4.1 Price/Earnings Ratio

  • LIVN is valuated correctly with a Price/Earnings ratio of 15.88.
  • Based on the Price/Earnings ratio, LIVN is valued cheaper than 86.41% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.45. LIVN is valued slightly cheaper when compared to this.
  • The Price/Forward Earnings ratio is 14.46, which indicates a correct valuation of LIVN.
  • LIVN's Price/Forward Earnings ratio is rather cheap when compared to the industry. LIVN is cheaper than 88.59% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.65, LIVN is valued a bit cheaper.
Industry RankSector Rank
PE 15.88
Fwd PE 14.46
LIVN Price Earnings VS Forward Price EarningsLIVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, LIVN is valued cheaply inside the industry as 85.33% of the companies are valued more expensively.
  • LIVN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. LIVN is cheaper than 90.76% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.54
EV/EBITDA 12.53
LIVN Per share dataLIVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • LIVN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.61
PEG (5Y)0.63
EPS Next 2Y8.87%
EPS Next 3Y9.5%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. LIVN Dividend Analysis

5.1 Amount

  • LIVN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

LIVN Fundamentals: All Metrics, Ratios and Statistics

LIVANOVA PLC

NASDAQ:LIVN (3/10/2026, 4:30:03 PM)

After market: 61.93 0 (0%)

61.93

-0.13 (-0.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-25
Earnings (Next)05-05
Inst Owners105.28%
Inst Owner Change-2.12%
Ins Owners0.27%
Ins Owner Change0.56%
Market Cap3.39B
Revenue(TTM)1.39B
Net Income(TTM)-242.47M
Analysts82.35
Price Target73.19 (18.18%)
Short Float %3.74%
Short Ratio2.91
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.93%
Min EPS beat(2)3.44%
Max EPS beat(2)18.42%
EPS beat(4)4
Avg EPS beat(4)13.83%
Min EPS beat(4)3.44%
Max EPS beat(4)20.31%
EPS beat(8)7
Avg EPS beat(8)17.63%
EPS beat(12)11
Avg EPS beat(12)17.8%
EPS beat(16)14
Avg EPS beat(16)14%
Revenue beat(2)2
Avg Revenue beat(2)1.13%
Min Revenue beat(2)0.14%
Max Revenue beat(2)2.12%
Revenue beat(4)4
Avg Revenue beat(4)2.26%
Min Revenue beat(4)0.14%
Max Revenue beat(4)4.01%
Revenue beat(8)7
Avg Revenue beat(8)2.08%
Revenue beat(12)11
Avg Revenue beat(12)3.31%
Revenue beat(16)14
Avg Revenue beat(16)2.76%
PT rev (1m)0%
PT rev (3m)5.94%
EPS NQ rev (1m)-1.11%
EPS NQ rev (3m)-0.02%
EPS NY rev (1m)1.61%
EPS NY rev (3m)1.53%
Revenue NQ rev (1m)1.87%
Revenue NQ rev (3m)1.86%
Revenue NY rev (1m)0.93%
Revenue NY rev (3m)0.87%
Valuation
Industry RankSector Rank
PE 15.88
Fwd PE 14.46
P/S 2.44
P/FCF 19.54
P/OCF 13.32
P/B 2.82
P/tB 19.12
EV/EBITDA 12.53
EPS(TTM)3.9
EY6.3%
EPS(NY)4.28
Fwd EY6.92%
FCF(TTM)3.17
FCFY5.12%
OCF(TTM)4.65
OCFY7.51%
SpS25.38
BVpS21.94
TBVpS3.24
PEG (NY)1.61
PEG (5Y)0.63
Graham Number43.88
Profitability
Industry RankSector Rank
ROA -9.3%
ROE -20.21%
ROCE 11.34%
ROIC 8.12%
ROICexc 12.57%
ROICexgc 104.62%
OM 14.69%
PM (TTM) N/A
GM 68.04%
FCFM 12.48%
ROA(3y)-2.02%
ROA(5y)-3.2%
ROE(3y)-4.68%
ROE(5y)-6.34%
ROIC(3y)5.19%
ROIC(5y)4.15%
ROICexc(3y)7.23%
ROICexc(5y)5.51%
ROICexgc(3y)42.15%
ROICexgc(5y)N/A
ROCE(3y)7.24%
ROCE(5y)5.79%
ROICexgc growth 3Y126.15%
ROICexgc growth 5YN/A
ROICexc growth 3Y56.54%
ROICexc growth 5YN/A
OM growth 3Y22.55%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.73%
GM growth 5Y1.24%
F-Score5
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 2.17
Debt/EBITDA 1.38
Cap/Depr 175.19%
Cap/Sales 5.84%
Interest Coverage 6.56
Cash Conversion 101.65%
Profit Quality N/A
Current Ratio 1.36
Quick Ratio 1.16
Altman-Z 1.76
F-Score5
WACC8.7%
ROIC/WACC0.93
Cap/Depr(3y)118.73%
Cap/Depr(5y)92.37%
Cap/Sales(3y)4.21%
Cap/Sales(5y)3.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.73%
EPS 3Y17.57%
EPS 5Y25.16%
EPS Q2Q%6.17%
EPS Next Y9.85%
EPS Next 2Y8.87%
EPS Next 3Y9.5%
EPS Next 5Y10.89%
Revenue 1Y (TTM)10.74%
Revenue growth 3Y10.75%
Revenue growth 5Y8.24%
Sales Q2Q%12.15%
Revenue Next Year7.68%
Revenue Next 2Y7.17%
Revenue Next 3Y7.09%
Revenue Next 5Y6.16%
EBIT growth 1Y25.59%
EBIT growth 3Y35.73%
EBIT growth 5YN/A
EBIT Next Year27.48%
EBIT Next 3Y13.13%
EBIT Next 5Y-0.2%
FCF growth 1Y27.48%
FCF growth 3Y58.64%
FCF growth 5YN/A
OCF growth 1Y38.95%
OCF growth 3Y53.79%
OCF growth 5YN/A

LIVANOVA PLC / LIVN FAQ

Can you provide the ChartMill fundamental rating for LIVANOVA PLC?

ChartMill assigns a fundamental rating of 5 / 10 to LIVN.


Can you provide the valuation status for LIVANOVA PLC?

ChartMill assigns a valuation rating of 6 / 10 to LIVANOVA PLC (LIVN). This can be considered as Fairly Valued.


What is the profitability of LIVN stock?

LIVANOVA PLC (LIVN) has a profitability rating of 6 / 10.


What is the financial health of LIVANOVA PLC (LIVN) stock?

The financial health rating of LIVANOVA PLC (LIVN) is 4 / 10.


Can you provide the expected EPS growth for LIVN stock?

The Earnings per Share (EPS) of LIVANOVA PLC (LIVN) is expected to grow by 9.85% in the next year.